Publications by authors named "Lory Cory"
Gynecol Oncol
January 2024
Article Synopsis
- The study aimed to investigate how common ERBB2/HER2 gene amplification is in patients with gynecologic cancers, focusing on endometrial, ovarian, and cervical cancers.
- Researchers analyzed data from the AACR Genomics Evidence of Neoplasia Information Exchange database, finding that out of 6961 patients, 3.8% had ERBB2 amplification, with the highest rates in mucinous ovarian (14.4%) and uterine serous (13.2%) cancers.
- The results indicated that ERBB2 amplification is notably prevalent in certain types of uterine and ovarian cancers but rare in endometrioid endometrial cancer, particularly in patients without TP53 mutations.
